Skip to content

Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm

Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00488943
Enrollment
300
Registered
2007-06-20
Start date
2005-01-01
Completion date
2009-12-01
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Keywords

Stent-Graft, AAA, Abdominal Aortic Anuerysm, Zenith, Endovascular, Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm

Brief summary

To collect and analyze clinical follow-up data which can be used to assess the safety, efficacy, and durability of endovascular AAA repair with Zenith and Chuter-Gianturco stent-grafts.

Detailed description

We propose to analyze the data collected for clinical purposes in 453 patients who already underwent endovascular AAA repair at UCSF and SFVA, and others who will undergo this operation in the future. Most of these patients have now passed the 2-year follow-up required by the original protocol, all continue to be followed for clinical purposes, using the same studies, the same data forms and the same schedule as before, because studies of various devices of this type have shown that the potential for late problems requires continuing scrutiny of stent-graft structure and function, as a basis for timely re-intervention.

Interventions

DEVICEAAA Endovascular Bifurcated Stent-Graft

Treatment of Abdominal Aortic Aneurysm with a Zenith Endovascular Bifurcated Stent-Graft.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* AAA with diameter \> 4 cm or AAA with a history of growth \> 0.5 cm per year * treatment of AAA with Zenith Stent-Graft

Exclusion criteria

* Pregnant * Life expectancy less than two years * Less than 18 years of age * Unwilling to comply with clinical follow-up schedule * Inability or refusal to give informed consent

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORTimothy AM Chuter, MD

Professor of Surgery

PRINCIPAL_INVESTIGATORJoseph H Rapp, MD

Professor of Surgery

PRINCIPAL_INVESTIGATORLinda M Reilly, MD

Professor of Surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026